NEW YORK (GenomeWeb) – DiagnoCure announced this week that the proxy advisory firms Institutional Shareholder Services and Glass Lewis have recommended that DiagnoCure shareholders vote to approve the sale of its PCA3 assets to Hologic subsidiary Gen-Probe. The sale was first announced in December — Gen-Probe will pay approximately $4.7 million for the assets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.